167 related articles for article (PubMed ID: 36309085)
1. Inflammasome sensor NLRP1 disease variant M1184V promotes autoproteolysis and DPP9 complex formation by stabilizing the FIIND domain.
Moecking J; Laohamonthonkul P; Meşe K; Hagelueken G; Steiner A; Harapas CR; Sandow JJ; Graves JD; Masters SL; Geyer M
J Biol Chem; 2022 Dec; 298(12):102645. PubMed ID: 36309085
[TBL] [Abstract][Full Text] [Related]
2. Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding.
Zhong FL; Robinson K; Teo DET; Tan KY; Lim C; Harapas CR; Yu CH; Xie WH; Sobota RM; Au VB; Hopkins R; D'Osualdo A; Reed JC; Connolly JE; Masters SL; Reversade B
J Biol Chem; 2018 Dec; 293(49):18864-18878. PubMed ID: 30291141
[TBL] [Abstract][Full Text] [Related]
3. DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation.
Hollingsworth LR; Sharif H; Griswold AR; Fontana P; Mintseris J; Dagbay KB; Paulo JA; Gygi SP; Bachovchin DA; Wu H
Nature; 2021 Apr; 592(7856):778-783. PubMed ID: 33731932
[TBL] [Abstract][Full Text] [Related]
4. NLRP1 variant M1184V decreases inflammasome activation in the context of DPP9 inhibition and asthma severity.
Moecking J; Laohamonthonkul P; Chalker K; White MJ; Harapas CR; Yu CH; Davidson S; Hrovat-Schaale K; Hu D; Eng C; Huntsman S; Calleja DJ; Horvat JC; Hansbro PM; O'Donoghue RJJ; Ting JP; Burchard EG; Geyer M; Gerlic M; Masters SL
J Allergy Clin Immunol; 2021 Jun; 147(6):2134-2145.e20. PubMed ID: 33378691
[TBL] [Abstract][Full Text] [Related]
5. Structural and biochemical mechanisms of NLRP1 inhibition by DPP9.
Huang M; Zhang X; Toh GA; Gong Q; Wang J; Han Z; Wu B; Zhong F; Chai J
Nature; 2021 Apr; 592(7856):773-777. PubMed ID: 33731929
[TBL] [Abstract][Full Text] [Related]
6. DPP9 deficiency: An inflammasomopathy that can be rescued by lowering NLRP1/IL-1 signaling.
Harapas CR; Robinson KS; Lay K; Wong J; Moreno Traspas R; Nabavizadeh N; Rass-Rothschild A; Boisson B; Drutman SB; Laohamonthonkul P; Bonner D; Xiong JR; Gorrell MD; Davidson S; Yu CH; Fleming MD; Gudera J; Stein J; Ben-Harosh M; Groopman E; Shimamura A; Tamary H; Kayserili H; Hatipoğlu N; Casanova JL; Bernstein JA; Zhong FL; Masters SL; Reversade B
Sci Immunol; 2022 Sep; 7(75):eabi4611. PubMed ID: 36112693
[TBL] [Abstract][Full Text] [Related]
7. DPP9's Enzymatic Activity and Not Its Binding to CARD8 Inhibits Inflammasome Activation.
Griswold AR; Ball DP; Bhattacharjee A; Chui AJ; Rao SD; Taabazuing CY; Bachovchin DA
ACS Chem Biol; 2019 Nov; 14(11):2424-2429. PubMed ID: 31525884
[TBL] [Abstract][Full Text] [Related]
8. The NLRP1 Inflammasome in Human Skin and Beyond.
Fenini G; Karakaya T; Hennig P; Di Filippo M; Beer HD
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32640751
[TBL] [Abstract][Full Text] [Related]
9. CARD8 and NLRP1 undergo autoproteolytic processing through a ZU5-like domain.
D'Osualdo A; Weichenberger CX; Wagner RN; Godzik A; Wooley J; Reed JC
PLoS One; 2011; 6(11):e27396. PubMed ID: 22087307
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl peptidase 9 sets a threshold for CARD8 inflammasome formation by sequestering its active C-terminal fragment.
Sharif H; Hollingsworth LR; Griswold AR; Hsiao JC; Wang Q; Bachovchin DA; Wu H
Immunity; 2021 Jul; 54(7):1392-1404.e10. PubMed ID: 34019797
[TBL] [Abstract][Full Text] [Related]
11. Role of the NLRP1 inflammasome in skin cancer and inflammatory skin diseases.
Calabrese L; Fiocco Z; Mellett M; Aoki R; Rubegni P; French LE; Satoh TK
Br J Dermatol; 2024 Feb; 190(3):305-315. PubMed ID: 37889986
[TBL] [Abstract][Full Text] [Related]
12. DPP8/DPP9 inhibition elicits canonical Nlrp1b inflammasome hallmarks in murine macrophages.
de Vasconcelos NM; Vliegen G; Gonçalves A; De Hert E; Martín-Pérez R; Van Opdenbosch N; Jallapally A; Geiss-Friedlander R; Lambeir AM; Augustyns K; Van Der Veken P; De Meester I; Lamkanfi M
Life Sci Alliance; 2019 Feb; 2(1):. PubMed ID: 30718379
[TBL] [Abstract][Full Text] [Related]
13. DPP8/9 inhibitors are universal activators of functional NLRP1 alleles.
Gai K; Okondo MC; Rao SD; Chui AJ; Ball DP; Johnson DC; Bachovchin DA
Cell Death Dis; 2019 Aug; 10(8):587. PubMed ID: 31383852
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for distinct inflammasome complex assembly by human NLRP1 and CARD8.
Gong Q; Robinson K; Xu C; Huynh PT; Chong KHC; Tan EYJ; Zhang J; Boo ZZ; Teo DET; Lay K; Zhang Y; Lim JSY; Goh WI; Wright G; Zhong FL; Reversade B; Wu B
Nat Commun; 2021 Jan; 12(1):188. PubMed ID: 33420028
[TBL] [Abstract][Full Text] [Related]
15. Protein folding stress potentiates NLRP1 and CARD8 inflammasome activation.
Orth-He EL; Huang HC; Rao SD; Wang Q; Chen Q; O'Mara CM; Chui AJ; Saoi M; Griswold AR; Bhattacharjee A; Ball DP; Cross JR; Bachovchin DA
Cell Rep; 2023 Jan; 42(1):111965. PubMed ID: 36649711
[TBL] [Abstract][Full Text] [Related]
16. Activation of the NLRP1 Inflammasome and Its Role in Transmissible Gastroenteritis Coronavirus Infection.
He H; Wang W; Li L; Zhang X; Shi H; Chen J; Shi D; Xue M; Feng L
J Virol; 2023 Jun; 97(6):e0058923. PubMed ID: 37255428
[TBL] [Abstract][Full Text] [Related]
17. The CARD8 T60 variant associates with NLRP1 and negatively regulates its activation.
Xu Z; Deng S; Huang Y; Yang Y; Sun L; Liu H; Zhao D; Zeng W; Yin X; Zheng P; Wang Y; Liu M; Zhao W; Xiao TS; Zhou Y; Jin T
Front Immunol; 2022; 13():1047922. PubMed ID: 36426349
[TBL] [Abstract][Full Text] [Related]
18. Autolytic proteolysis within the function to find domain (FIIND) is required for NLRP1 inflammasome activity.
Finger JN; Lich JD; Dare LC; Cook MN; Brown KK; Duraiswami C; Bertin J; Gough PJ
J Biol Chem; 2012 Jul; 287(30):25030-7. PubMed ID: 22665479
[TBL] [Abstract][Full Text] [Related]
19. The NLRP1 and CARD8 inflammasomes.
Taabazuing CY; Griswold AR; Bachovchin DA
Immunol Rev; 2020 Sep; 297(1):13-25. PubMed ID: 32558991
[TBL] [Abstract][Full Text] [Related]
20. Hemophagocytic lymphohistiocytosis-like hyperinflammation due to a de novo mutation in DPP9.
Wolf C; Fischer H; Kühl JS; Koss S; Jamra RA; Starke S; Schultz J; Ehl S; Neumann K; Schuetz C; Huber R; Hornung V; Lee-Kirsch MA
J Allergy Clin Immunol; 2023 Nov; 152(5):1336-1344.e5. PubMed ID: 37544411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
